Future Farm Technologies subsidiary, CEPG Consulting and Design Inc. (CEPG), located in St. Johns, Newfoundland, has been issued a cannabis research license in accordance with Health Canada's Cannabis Act and Cannabis Regulations.
"The license authorizes CEPG to possess and produce cannabis for the purpose of research activities at its locations in Jackson's Arm and St. John's and at Memorial University of Newfoundland," the team with the company explains. "Health Canada's Research Protocol requires the research to be for: Creation, classification and characterization of elite Cannabis clones with a profile of Cannabinoids and terpenes specifically selected for pharmaceutical and industrial applications."
"We are thrilled to receive this cannabis research license from Health Canada," says Future Farm CEO William Gildea. "This license allows us to begin work creating elite new strains of cannabis and is the first step towards reaching our ultimate goal of mass-producing elite cannabis plant clones for sale throughout Canada. We could not have achieved this milestone without the leadership and hard work of CEPGs President and CEO, Mr. H.C. Snellen, CFO and Director Mr. H.B. Chislett and regulatory specialist Mr. Gary Harnum."
For more information:
Future Farm Technologies
342 Compass Circle
North Kingstown RI 02852
T: (617) 834-9467
[email protected]
futurefarmtech.com